Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 2,592 shares at $162.47 ($421K) on 2024-05-28, disclosed to the SEC on 2024-05-29.
Scheduled sale ($421k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $162.47 | 1,296 | $211K | 50.0% |
| 2 | $162.47 | 1,296 | $211K | 50.0% |
| Total | $162.47 avg | 2,592 | $421K | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |